{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:23:15Z","timestamp":1790839395745,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.aca.2016.06.054","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T14:08:02Z","timestamp":1467554882000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["UPLC-MS\/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses"],"prefix":"10.1016","volume":"936","author":[{"given":"Christiane","family":"Auray-Blais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassili","family":"Valayannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Raiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Beaudoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Maranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2587-2871","authenticated-orcid":false,"given":"Joe T.R.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2016.06.054_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J.\u00a0Pediatr."},{"issue":"Suppl.\u00a05","key":"10.1016\/j.aca.2016.06.054_bib2","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.aca.2016.06.054_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"issue":"1","key":"10.1016\/j.aca.2016.06.054_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14728214.2016.1123690","article-title":"Emerging drugs for the treatment of mucopolysaccharidoses","volume":"21","author":"Giugliani","year":"2016","journal-title":"Opin. Emerg. Drugs"},{"issue":"6","key":"10.1016\/j.aca.2016.06.054_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00005-012-0195-9","article-title":"Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses","volume":"60","author":"Banecka-Majkutewicz","year":"2012","journal-title":"Immunol. Ther. Exp."},{"issue":"4","key":"10.1016\/j.aca.2016.06.054_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2012.05.003","article-title":"Biomarkers for the mucopolysaccharidoses: discovery and clinical utility","volume":"106","author":"Clarke","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.aca.2016.06.054_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0009-8981(85)90318-3","article-title":"Screening test for urinary glycosaminoglycans and differentiation of various mucopolysaccharidoses","volume":"151","author":"Huang","year":"1985","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.aca.2016.06.054_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0009-9120(87)80088-7","article-title":"Screening for mucopolysaccharide disorders with the Berry spot test","volume":"20","author":"Berry","year":"1987","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.aca.2016.06.054_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1258\/000456307780945688","article-title":"Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses \u2014 an evaluation","volume":"44","author":"Gray","year":"2007","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.aca.2016.06.054_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jcla.20375","article-title":"Neonatal screening for mucopolysaccharidoses by determination of glycosaminoglycans in the eluate of urine-impregnated paper: preliminary results of an improved DMB-based procedure","volume":"24","author":"Alonso-Fernandez","year":"2010","journal-title":"J.\u00a0Clin. Lab. Anal."},{"issue":"7","key":"10.1016\/j.aca.2016.06.054_bib11","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/clinchem\/35.7.1472","article-title":"Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses","volume":"35","author":"de Jong","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.aca.2016.06.054_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/nbm.833","article-title":"Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses","volume":"16","author":"Hochuli","year":"2003","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.aca.2016.06.054_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/clinchem\/39.1.163","article-title":"Pitfalls of screening for mucopolysaccharidoses by the Dimethylmethylene Blue test","volume":"39","author":"Piraud","year":"1993","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.aca.2016.06.054_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2010.09.003","article-title":"Efficient analysis of urinary glycosaminoglycans by LC-MS\/MS in mucopolysaccharidoses type I, II and VI","volume":"102","author":"Auray-Blais","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"7\u20138","key":"10.1016\/j.aca.2016.06.054_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cca.2012.01.012","article-title":"An improved method for glycosaminoglycan analysis by LC-MS\/MS of urine samples collected on filter paper","volume":"413","author":"Auray-Blais","year":"2012","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.aca.2016.06.054_bib16","first-page":"12","article-title":"Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"17","author":"Zhang","year":"2013","journal-title":"Curr. Protoc. Hum. Genet."},{"issue":"3","key":"10.1016\/j.aca.2016.06.054_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4155\/bio.15.239","article-title":"Evaluation of urinary keratan sulfate disaccharides in MPS IVA patients using UPLC-MS\/MS","volume":"8","author":"Auray-Blais","year":"2016","journal-title":"Bioanalysis"},{"issue":"2","key":"10.1016\/j.aca.2016.06.054_bib18","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.ymgme.2014.12.017","article-title":"Urine keratan sulfate (uKS) elevation in lysosomal disorders (LSD): comparison of uKS levels in Morquio\/MPS IV versus non-Morquio LSD","volume":"114","author":"Auray-Blais","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.aca.2016.06.054_bib19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","article-title":"Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry","volume":"57","author":"Zhang","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.aca.2016.06.054_bib20","first-page":"19","article-title":"Newborn screening and diagnosis of mucopolysaccharidoses: application of tandem mass spectrometry","volume":"24","author":"Tomatsu","year":"2014","journal-title":"Nihon Masu Sukuriningu Gakkai Shi"},{"issue":"3","key":"10.1016\/j.aca.2016.06.054_bib21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo4030655","article-title":"Establishment of glycosaminoglycan assays for mucopolysaccharidoses","volume":"4","author":"Tomatsu","year":"2014","journal-title":"Metabolites."},{"key":"10.1016\/j.aca.2016.06.054_bib22","first-page":"1","article-title":"Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis II, IVA, and IVB","volume":"21","author":"Shimada","year":"2015","journal-title":"J.\u00a0Inherit. Metab. Dis. Rep."},{"issue":"4","key":"10.1016\/j.aca.2016.06.054_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4155\/bio.15.243","article-title":"A\u00a0novel LC\u2013MS\/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients","volume":"8","author":"Naimy","year":"2016","journal-title":"Bioanalysis"},{"issue":"4","key":"10.1016\/j.aca.2016.06.054_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15216540214923","article-title":"Biosynthesis of chondroitin\/dermatan sulfate","volume":"54","author":"Silbert","year":"2002","journal-title":"IUBMB Life"},{"key":"10.1016\/j.aca.2016.06.054_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/B978-0-12-396527-1.00003-6","article-title":"Strategies in synthesis of heparin\/heparan sulfate oligosaccharides: 2000-present","volume":"67","author":"Dulaney","year":"2012","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1016\/j.aca.2016.06.054_bib26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijbiomac.2014.08.029","article-title":"Keratan sulfate: an up-to-date review","volume":"72","author":"Pomin","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.aca.2016.06.054_bib27","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1021\/ac203433e","article-title":"Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics","volume":"84","author":"Auray-Blais","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2016.06.054_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-005-5673-3","article-title":"Keratan sulfate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.aca.2016.06.054_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10545-005-0069-y","article-title":"Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.aca.2016.06.054_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"Rowan","year":"2013","journal-title":"J.\u00a0Inherit. Metab. Dis."}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267016308170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267016308170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:48:11Z","timestamp":1617238091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267016308170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":30,"alternative-id":["S0003267016308170"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2016.06.054","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UPLC-MS\/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2016.06.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}